Paper Review Records
全部论文审稿周期
16 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
212
天
Dopamine-related alterations in functional brain network dynamic reconfiguration in Parkinson’s disease
作者
AmirHussein Abdolalizadeh; Micha Burkhardt; Paria Jahansa; Carsten Gießing; Karsten Witt; Christiane M. Thiel展开收起
作者单位
1. Biological Psychology Lab, Department of Psychology, School of Medicine and Health Sciences, Carl von Ossietzky Universität Oldenburg, Oldenburg, Germany; 2. Psychological Methods and Statistics, Department of Psychology, School of Medicine and Health Sciences, Carl von Ossietzky Universität Oldenburg, Oldenburg, Germany; 3. Mathematical Psychology, Department of Psychology, School of Medicine and Health Sciences, Carl von Ossietzky Universität Oldenburg, Oldenburg, Germany; 4. Research Center Neurosensory Science, Carl von Ossietzky Universität Oldenburg, Oldenburg, Germany; 5. Department of Neurology, School of Medicine and Health Sciences, Carl von Ossietzky Universität Oldenburg, Oldenburg, Germany展开收起
146
天
Considerations on combination therapies for disease modification in Parkinson’s
作者
Rachel M. Hughes; Aleksandra Pilcicka; Trevor Klee; Fiona Ducotterd; Heather Mortiboys; Simon R. W. Stott展开收起
作者单位
1. Cure Parkinson’s, London, UK; 2. Highway Pharmaceuticals, Boston, USA; 3. Alzheimer’s Research UK UCL Drug Discovery Institute, University College London, London, UK; 4. Sheffield Institute for Translational Neuroscience (SITraN), School of Medicine and Population Health, University of Sheffield, Sheffield, UK展开收起
246
天
Lewy pathology largely absent in prefrontal cortices of Parkinson’s disease patients undergoing deep brain stimulation
作者
Ariela S. Buxbaum Grice; Brian H. Kopell; Klaudia F. Laborc; Anina N. Lund; Renata Gonzalez Chong; Meredith Spadaccia; Gerard Ona; Girish Nadkarni; John F. Crary; Alexander W. Charney; Noam D. Beckmann展开收起
作者单位
1. Icahn School of Medicine at Mount Sinai, New York, USA; 2. Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, USA; 3. Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, USA; 4. Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, USA; 5. Windreich Department of Artificial Intelligence and Human Health, Icahn School of Medicine at Mount Sinai, New York, USA; 6. Center for Neuromodulation, Icahn School of Medicine at Mount Sinai, New York, USA; 7. Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, USA; 8. Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, USA; 9. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA; 10. Department of Pathology, Molecular and Cell-based Medicine, Icahn School of Medicine at Mount Sinai, New York, USA; 11. Neuropathology Brain Bank & Research CoRE, Icahn School of Medicine at Mount Sinai, New York, USA; 12. Ronald M. Loeb Center for Alzheimer’s Disease, Icahn School of Medicine at Mount Sinai, New York, USA; 13. The Hasso Plattner Institute for Digital Health at Mount Sinai, New York, USA; 14. Department of Medicine, Division of Data Driven and Digital Medicine (D3M), Icahn School of Medicine at Mount Sinai, New York, USA展开收起
297
天
A comprehensive assessment of lifecourse and mortality of Parkinson’s disease in the German National Cohort
作者
Klaus Berger; André Karch; Christina M. Lill; Tom L. Berger; Ulrich Mueller; Michael Bartl; Brit Mollenhauer; Beate Fischer; Karin B. Michels; Philipp T. Meyer; Verena A. Katzke; Jara Sabin; Stefan N. Willich; Thomas Keil; Stefanie Castell; Anja M. Hauri; Matthias B. Schulze; Tamara Schikowski; Oliver Riedel; Tobias Pischon; Ilais Moreno Velasquez; Sebastian Heinzel; Hermann Brenner; Annette Peters; Rafael Mikolajczyk; Theresa Herrmann; Claudia Trenkwalder展开收起
作者单位
1. Institute of Epidemiology and Social Medicine, University of, Münster, Germany; 2. Ageing Epidemiology Research Unit (AGE), School of Public Health, Imperial College London, London, UK; 3. Institute for Health Services Research and Clinical Epidemiology, Medical School, Philipps-University, Marburg, Germany; 4. Department of Neurology, University Medical Center, Goettingen, Germany; 5. Paracelsus-Elena Klinik, Center for Parkinsonism and Movement Disorders, Kassel, Germany; 6. Institute for Epidemiology and Preventive Medicine, University of Regensburg, Bavaria, Germany; 7. Institute for Prevention and Cancer Epidemiology, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany; 8. Department of Nuclear Medicine, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 9. Division of Cancer Epidemiology C020, German Cancer Research Center (DKFZ), Heidelberg, Germany; 10. Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Berlin, Germany; 11. Institute of Clinical Epidemiology and Biometry, University of Wuerzburg, Wuerzburg, Germany; 12. State Institute of Health I, Bavarian Health and Food Safety Authority, Erlangen, Germany; 13. Department for Epidemiology, Helmholtz Centre for Infection Research, Brunswick, Germany; 14. Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 15. Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany; 16. IUF-Leibniz Institut für umweltmedizinische Forschung, Düsseldorf, Germany; 17. Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany; 18. Molecular Epidemiology Research Group, Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany; 19. Biobank Technology Platform, Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany; 20. Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; 21. Department of Neurology, Kiel University, University Medical Centre Schleswig-Holstein, Kiel, Germany; 22. Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany; 23. Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany; 24. Institute for Medical Information Processing, Biometry and Epidemiology (IBE), Faculty of Medicine, LMU Munich, Munich, Germany; 25. Institute for Medical Epidemiology, Biometrics, and Informatics, Interdisciplinary Center for Health Sciences, Medical Faculty of the Martin Luther University Halle-Wittenberg, Halle(Saale), Germany; 26. Dept. Neurosurgery, University Medical Center, Goettingen, Germany展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天